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Abstract  
Background 
Altered physical activity is an important feature of depression. It is manifested in 
psychomotor retardation, agitation and withdrawal from engagement in normal 
activities. Modern devices for activity monitoring (actigraphs) make it possible to 
monitor physical activity unobtrusively but the validity of actigraphy as an indicator 
of mood state is uncertain. We carried out a systematic review of digital actigraphy in 
patients with depression to investigate the associations between measured physical 
activity and depression.  
Methods 
Systematic review and meta-analysis. Studies were identified from Medline, 
EMBASE and Psycinfo databases and included if they were either case control or 
longitudinal studies of actigraphy in adults aged between 18 and 65 diagnosed with a 
depressive disorder. Outcomes were daytime and night-time activity and actigraphic 
measures of sleep.  
Results 
We identified 19 eligible papers from 16 studies (412 patients). Case control studies 
showed less daytime activity in patients with depression (standardised mean 
difference -0.76, 95% confidence intervals -1.05 to -0.47). Longitudinal studies 
showed moderate increase in daytime activity (0.53, 0.20 to 0.87) and a reduction in 
night-time activity (-0.36, -0.65 to -0.06) over the course of treatment. 
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Limitations 
All study participants were unblinded. Only 7 papers included patients treated in the 
community.  
Conclusions 
Actigraphy is a potentially valuable source of additional information about patients 
with depression. However, there are no clear guidelines for use of actigraphy in 
studies of patients with depression. Further studies should investigate patients treated 
in the community. Additional work to develop algorithms for differentiating 
behaviour patterns is also needed.  
 
 
KEYWORDS: Depressive disorder; actigraphy; telemonitoring. 
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Background  
Altered physical activity has long been recognised as a feature of depression (Parker 
and Brotchie, 1992). Psychomotor retardation is argued to be a cardinal feature of 
melancholia (Parker et al., 1995) but other forms of altered physical activity in 
depression include agitation and withdrawal from normal activities of daily living. 
Reports of activity, either observed or self reported, are features of many validated 
depression assessment tools (Hamilton, 1960; Kroenke et al., 2001).  
 
Objective measurement of activity (actigraphy) using body-worn accelerometers has 
been available in research settings for over 20 years and accelerometers have been used 
extensively in research in a wide range of situations to measure both daytime activity 
(Matthews et al., 2012) and sleep (Martin and Hakim, 2011). In recent years devices 
incorporating these technologies have become widely available, and - in the case of 
smartphones – ubiquitous. Much of their use is currently driven by the health and 
lifestyle market. While research and commercial applications are beginning to use 
activity monitoring in patients with depression (Help4Mood Consortium, 2012;ICT4 
Depression Consortium, 2012;Monarca Project, 2012;Optimi Consortium, 2012), we 
were unable to find a recent systematic review of the extent to which actigraphic 
measures of activity correspond to clinically meaningful changes in depression. We 
were also unable to find any guidelines for the use of activity monitoring in depression 
in order to recommend, for instance,  how long patients should wear the actigraphy 
device or what is the best way of characterising activity patterns during the 
measurement period.  
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We carried out a systematic review of published studies in which actigraphy was used 
to monitor day or night time activity in people with a depressive disorder. We included 
both case-control studies which examined the difference between people with 
depression and healthy controls and longitudinal (pre-post) treatment studies to 
investigate changes over time.  The review had two aims: 
(1) to examine the association between activity levels and depression  
(2) to identify areas of research that need to be addressed before guidelines for the use 
of actigraphy in people with depression can be developed 
 
Methods 
The study was conducted in accordance with PRISMA statement (Moher et al 2009) 
and the protocol was agreed by all authors in advance of data collection. As the study 
included no direct involvement with patients or identifiable data no ethical review was 
necessary.  
Eligibility 
We included case-control and longitudinal treatment studies of adults aged between 18 
and 65 which used actigraphy. At least one group in the study was required to have a 
confirmed diagnosis of major depressive disorder, depression in association with 
bipolar disorder, or Seasonal Affective Disorder (SAD) during the winter season. 
Eligible studies could include participants treated in hospital or at home.  
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Search Strategy 
We searched Medline, PsychInfo and EMBASE databases for publications between 
1966 and April 2012 which included the MESH heading depression/  and one or more 
of  the eight terms monitoring, ambulatory/, motor activity/, actigrap$ or actimet$ or 
actograp$, actomet$  or accelerometer. We also followed references from retrieved 
publications and searched Google Scholar for relevant grey literature.  
  
Study Selection 
After removal of duplicates, two authors (CB and MW) reviewed the titles of all 
publications identified by the searches to identify potentially eligible abstracts. The 
same two authors independently and then jointly selected studies for detailed extraction 
based on the full abstract. Studies were eligble if they included appropriate data from 
adults aged 18-65 with a diagnosis of depression. Studies were excluded if they 
included only patients with bipolar disorder, or were limited to patients with potentially 
confounding conditions - mostly cancer. Where two or more publications appeared to 
relate to the same data, we included both provided they reported on separate measures 
(for instance sleep in one and daytime activity in another). For each included study two 
authors (CB plus either AS, ASB, BM or MW) independently extracted data onto a 
form that had been developed by CB for this review.  The data comprised study design 
and location; characteristics of the sample (patient and where relevant control), 
actigraphic monitoring parameters (duration of monitoring, quantifications of activity) 
and relevant outcomes.   
 
As part of the data extraction, studies were assessed for risk of bias in relation to patient 
recruitment, blinding of analysis, potential confounders, multiple publication, and 
 - 7 - 
reporting bias (such as failure to report hypotheses which were tested and over-reliance 
on post-hoc analysis). Any discrepancies were corrected by referring to original studies 
and resolved by consensus. 
Choice of outcomes 
In advance of data extraction, we specified two primary outcomes: day-time activity 
and night-time activity (each recorded as total or average counts for all, or a substantial 
portion of, the relevant time period). We aimed to examined these separately in case-
control and longitudinal studies. In addition, after reading the eligible papers, we 
included four additional outcomes: sleep efficiency, sleep duration, and two measures 
of diurnal variation – intra-day variability, i.e., variation in activity levels within one 
day, and inter-day stability, i.e., variation in activity levels from day to day.  
 
Data analysis  
From each study we extracted data on daytime and night time activity as available. 
Where studies reported total (or average) daytime activity we used this; where studies 
chose other time periods, such as total 24 hour activity or most active 10 hours we 
extracted these.  From each set of data we calculated a measure of the difference 
between groups (either case-control or pre-post treatment) using the standardized mean 
difference.  We made forest plots of all comparisons and assessed heterogeneity 
between studies. Heterogeneity was reported as the I2 statistic, where higher values 
indicate greater heterogeneity and values of over 50% may indicate substantial 
heterogeneity (Higgins and Green  2011). Where heterogeneity was less than 50% we 
carried out meta-analysis using a random effects model because of the variety within 
study populations with respect to severity, location and treatment. 




The initial search returned 1267 titles.  From these and subsequent following of 
references, we reviewed 81 abstracts and obtained full texts for 24 publications from 20 
studies. In addition data from two papers which were no longer available (Foster et al., 
1978; 9) were extracted from an earlier review (Teicher, 1995) resulting in a total of 26 
papers for data extraction. This is summarised in Figure 1. Following data extraction 8 
papers were excluded: 3 for having no interpretable data (Iverson, 2004; Ueda et al., 
2005; Wolff, III et al., 1985), two conference abstracts with insufficient data (Deoras et 
al., 2010;   Kelly et al., 2009), two for inappropriate comparisons (Lemke et al., 1998; 
Mendlowicz et al., 1999) and one as an exploratory study of non-linear dynamic 
measures of variability (Hauge et al., 2011). This left 19 papers from 16 studies suitable 
for detailed comparison(Baune et al 2006;  Baune et al 2007;  Berle et al., 2010;   
Coffield and Tryon, 2004; Faurholt-Jepsen et al., 2012; Foster et al., 1978; Glod et al 
1992;  Godfrey and Knight, 1984;  Haynes et al., 2006; Joffe et al., 2009;Korszun et al., 
2002; Raoux, 1994; Royant-Parola et al., 1986; Teicher et al., 1997; Todder et al., 
2006; Todder et al., 2007; Volkers et al., 2002; Volkers et al., 2003; Winkler et al., 
2005) 
Study characteristics 
Relevant study characteristics are summarized in Table 1 which also includes a 
reference number for each study. Eleven publications were from Europe (4 from 
Germany, 2 from the Netherlands and one each from Austria, Denmark, France, 
Norway and UK), 7 from the USA and 1 from New Zealand.  Thirteen papers reported 
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on hospital inpatients, 7 reported data from outpatients or primary care patients (one 
paper included both).  
 
Of the 19 papers, eight included patients with major depression in association with 
bipolar disorder,  five with type II only (1-4;10) and three with both type I and type II 
(5;14;15). One included a separate group of patients with bipolar disorder – these were 
not included in the analysis. Three papers examined depression in patients with 
Seasonal Affective Disorder   (9;16;19). The diagnosis of major depressive disorder 
was confirmed using a standardised interview in 13 papers; most of those without 
structured interview inclusion took place before 1995.  
 
Most study populations had a greater proportion of female than male participants 
(median 57, interquartile range 43 to 80). Studies had a broadly similar average 
participant age, (median 44, interquartile range 38 to 50 years). Antidepressant drug 
treatment was prescribed in 11 studies (1-5; 8;11;13-15;17), and stated to be not 
prescribed in 4 (of which 3 were studies of seasonal affective disorder) (9;16;18;19). 
Antidepressant prescribing was not reported in 3 papers (6;10;12). The antidepressant 
drugs prescribed varied within and between studies, generally using conventional 
treatment at the time the study was conducted, one study allocated patients to either a 
tricyclic antidepressant or selective serotonin reuptake inhibitor (SSRI) (17). An 
atypical antipsychotic (quetiapine) was routinely prescribed in 5 papers (1-5).  
 
 - 10 - 
Study design, risk of bias and confounding 
Eleven papers reported a case control design (4;5; 8-13;16;18;19) and 10 reported 
before and after treatment comparisons for patients (1-4;6;10;14;15;17;19), of which 3 
papers reported also data from healthy controls (10;4;19).  
 
All papers reported either day time or sleep actigraphy data and 7 of the 15 studies (11 
papers) reported both daytime and sleep data. While all studies used wrist actigraphy, 
they varied substantially in the activity measures reported and these are summarized in 
table 2. Because studies used a range of devices and differed in reporting periods (some 
reporting totals, others hourly averages) the reports of activity counts could not be 
directly compared between studies; however the use of standardized mean difference 
for comparisons allowed these to be combined in the meta-analysis ( Higgins and Green 
2011). 
 
Most studies contained significant risk of bias: all were observational studies in which 
participants were aware of their allocation group and of being recorded. Therefore, they 
may have altered behaviour accordingly. Most studies appeared to use opportunistic 
recruitment strategies such as available in-patients rather than systematic selection and 
few gave details of how many patients were considered but not eligible. Three studies 
carried out before 1995 failed to describe blinding of data analysts. We regarded studies 
of depressed hospital inpatients compared to community dwelling healthy controls as at 
high risk of confounding and thus having low external validity. Almost all studies were 
at some risk of confounding due to the effects of depression treatments and there was 
insufficient data to quantify this. Duplication bias was considered in a group of papers 
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which appeared to come from the same study although three of the four reported 
different data (1-4).  
 
Daytime activity  
Daytime activity was reported in 15 papers (1;2;4;5;7-10; 13-19).  Of these, 10 
compared data from cases and controls (4;5;7-10;13;16;18;19) and 8 made pre and post 
treatment comparisons (1;2;4;10;14;15;17;19).  Eleven papers included hospital in-
patients (1;2;4; 5; 8-10;14;15;17;18) and 4 papers included outpatients (5;7;13;16;19). 
Duration of monitoring varied between 3 and 30 days.  
 
Eight case control studies including 208 cases and 245 controls had sufficient data for 
quantitative comparison (5;7; 8;9;13;16;4;18;19). One included study reported the 
median value for both groups (7); the median was used in comparisons with the 
standard deviation calculated from the interquartile range. One study did not report the 
standard deviation data for controls and was excluded from the comparison (10). Meta-
analysis showed moderate heterogeneity between studies (I2= 47.5) and the results are 
shown in figure 2a. There was a significant difference in standardized mean daytime 
activity between cases and controls of -0.76 (-1.05 to -0.47); this was similar in studies 
involving inpatients (-0.8) and those conducted in outpatients (-0.72). 
 
Seven pre and post treatment studies, including 163 patients had sufficient data for 
quantitative comparison (2;4;10;14;15;17;19). Of these studies, 6 were conducted with 
hospital inpatients.  Figure 2b shows the forest plot of the meta-analysis. There was 
moderate heterogeneity between studies (I2= 48.4). There was a significant increase in 
standardized mean daytime activity following treatment of 0.53 (0.2 to 0.87).  
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Sleep and night-time activity  
Fourteen papers reported night time activity (1;3-6;8;9;11-14;17-19).  Of these, 9 
compared data from cases and controls (4;5; 8;9;11-13;18;19) and 7 made pre and post 
treatment comparisons (1;3;4;6;14;17;19). Ten papers included hospital in-patients (1; 
3-5;6;8;9;14;17;18) and 5 papers included outpatients (5; 11-13;19). Duration of 
monitoring varied between 2 and 14 nights.  
 
Night time actigraphic activity was reported in 6 case control studies, including 146 
cases and 179 controls with data suitable for quantitative comparison (4;5;8;9;13;18). 
All studies used in-patient cases compared to healthy controls living at home. Figure 2c 
shows the forest plot of the comparison. There was substantial heterogeneity between 
studies (I2= 88.9) and in view of this we made no estimate of an overall effect. 
 
Night time activity was also reported in 3 pre and post treatment studies, including 89 
patients (1; 4;17).  All 3 of these studies were conducted in hospital inpatients. Figure 
2d shows the forest plot of the meta-analysis. There was low heterogeneity between 
studies (I2= 0) and meta-analysis showed a small reduction in mean overnight activity 
following treatment -0.36 (-0.65 to -0.06).  
 
Sleep efficiency before and after treatment was reported in 2 studies (3; 19) and sleep 
duration in 3 (14; 3; 19). Effects appeared to be small, with pooled SMD of 0.19 (-0.38 
to 0.76) and -0.1 (-0.44 to 0.23) respectively. 
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Variability 
Two measures, inter-day stability and intra-day variability were reported before and 
after treatment in 2 studies (1; 5) including only 33 patients. There was no evidence of a 
meaningful difference, with pooled SMD of 0.15 (-0.35 to 0.65) and 0.04 (-0.44 to 
0.52) respectively.  
Discussion  
Summary of principal findings 
Actigraphy confirms the clinical impression that patients with depression display less 
day-time motor activity than healthy controls and that this activity increases over the 
course of treatment. Depressed patients appear to have increased night-time activity 
although this is not apparent in standard actigraphic measures of sleep duration or sleep 
efficiency.  Studies to date have used a wide range of protocols and most have been 
confined to hospital inpatients. 
Strengths and limitations 
This is the first review of actigraphy in patients with depression to take a systematic 
approach to literature searching and synthesis. Searching and data extraction were both 
carried out in parallel by two investigators, with discrepancies resolved by discussion. 
 
The principal limitation is the problem of combining such disparate studies. We 
considered whether, given the heterogeneity of depression, treatment and contexts, this 
was appropriate. We took the view that altered activity patterns may be present across a 
wide range of depressive disorders and as long as studies had suitably rigorous 
methods, then it would be appropriate to combine them, at least qualitatively. While the 
subgroup of studies including patients with SAD was too small for formal comparison 
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with other studies, qualitative inspection of the results suggests they were comparable 
with those of patients with non-seasonal depression. We included studies which in 
which the depressed patients included some with bipolar disorder. One study examined 
three groups: unipolar, bipolar and healthy controls and found a difference between 
depression types but there were insufficient data within other studies to examine this. 
 
We examined all studies systematically for sources of bias. The main problem we 
identified was with confounding – particularly in studies comparing depressed 
inpatients with healthy controls living in the community. Not surprisingly these studies 
showed large differences between groups which could have been accounted for by 
living environment and routines rather than by depression. In contrast, the longitudinal 
treatment studies were more robust to this form of confounding. We did not attempt to 
separate out drug treatment effects, firstly because in most studies patients received a 
mix of treatments and secondly because the agents in use changed repeatedly over the 
period from the first to the last of these studies.  
 
While the actigraphy devices in all the studies used the same principle of movement 
detection with a device containing an accelerometer attached to the patient’s wrist, not 
all studies mentioned the make and model of actigraph used. The most commonly used 
models were the MotionloggerTM Actigraph (Ambulatory Monitoring, Inc, Ardsley, 
NY) and the Actiwatch (Cambridge Neurotechnology Ltd, UK). None of the studies 
used waist actigraphy, which is a well-established method for data on daytime activity 
levels and exercise (Troiano et al., 2008). None of the sleep studies used 
polysomnography which is the gold standard for sleep assessment, although correlation 
of this with actigraphy appears to be good (McCall and McCall, 2012).  
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There was considerable variation in the duration of sampling ranging from twelve hours 
to more than two weeks. All but one study included data collection periods of at least 3 
days, as recommended in a review of actigraphy methods in cancer studies (Berger et 
al., 2008) although this may not be sufficient to minimise the influence of day to day 
variation (Baranowski et al., 2008). There was inconsistent reporting of depression 
severity, medication or other variables which may influence activity such as body mass 
index. In order to examine the influence of these factors would have required an 
individual patient meta-analysis which was outside the scope of this study. 
Interpretation 
Taken together, these studies provide good evidence of differences in the daytime 
activity of hospitalised patients with depression both compared to controls and over 
time. However, generalisability to people with depression living in the community is 
problematic. Most of the studies of outpatients examined patients with SAD or specific 
subgroups such as menopausal women; only one small study investigated daytime 
activity in non-seasonal depression (13). Most patients treated in the community will 
have milder forms of depression and less co-morbidity than those admitted to hospital 
and it is not clear from data in these studies whether changes in activity are limited to 
patients with more severe or melancholic depression. In future it may be that more 
sophisticated interpretation of actigraphy may be able to discriminate psychomotor 
retardation, agitation and normal activity. 
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Implications for research, policy and practice 
Actigraphy is a prominent feature of innovative telehealth approaches for monitoring 
the long-term health and recovery of people with depression (Help4Mood Consortium, 
2012;ICT4 Depression Consortium, 2012;Monarca Project, 2012;Optimi Consortium, 
2012). However, the results of this review suggest six issues that need to be addressed 
in order to ensure that activity monitoring is worthwhile:   
(1) Further evidence is needed to inform clinical guidelines for the use of actigraphy in 
the monitoring and management of depression, as has been proposed for patients with 
cancer (Berger et al., 2008).  These should take account of different patient populations 
(e.g. acute versus chronic cases) and settings (e.g. community versus hospital).  
(2) Field studies are needed in order to determine to what extent the activity levels of 
people with depression  living in the community differ from existing population norms 
(Troiano et al., 2008)  
(3) Longitudinal data is needed on the  correlation of actigraphy data in people living in 
the community with other validated measures used to assess recovery.  
(4) Very little is known about the acceptability of different actigraphy devices and 
protocols to people with depression. Such information is crucial for ensuring adherence 
to monitoring.  While almost all the studies reported here used a wrist-worn device, 
chest worn combined monitors may increase acceptability in addition to collecting 
additional data (Brage et al 2005). 
(5)  Analytical methods need to be improved to ensure all relevant features are 
extracted from actigraphy data (Hauge et al., 2011) (Nakamura et al., 2008). Methods 
need to be developed to categorise different behaviour types (Matthews et al., 2012) 
and standardised in order to capture any differences in the diurnal variation of activity. 
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(6) In view of the recent demonstration of differences in activity between patients with 
unipolar and bipolar depression (Faurholt-Jepsen et al 2012), further studies should 
characterise actigraphic differences between these two disorders. 
  
Collaboration between academic experts, clinicians and healthcare data custodians will 
be important in order to make best use of these new data streams for patient care and 
research. 
Conclusions  
Actigraphy is a potentially valuable source of additional information in patients with 
depression. Guidelines for use of actigraphy in studies of patients with depression are 
needed and further studies should investigate patients treated in the community and 
create analysis methods for differentiating relevant behaviour patterns. 
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Figure 1  Flowchart indicating number of eligible studies. 
 
 
(see separate png file)
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Figure 2  - Forest plots of systematic review of actigraphy using different study 
types and outcomes. 
 
 
(see separate png file)
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Table 1: Characteristics of study patient populations 
Study ID Paper Country Diagnosis1 Bipolar Age % 
female 
Scale2 Interview Drugs3 Notes 
Baune 1 Baune et al 2006 Germany MDD Type II 48 (16) 80 B,H SCID AD,AP 2/10 Bipolar II 
 2 Baune et al 2007 Germany MDD Type II 49 (13) 48 B,H SCID AD,AP Treatment Resistant Depression, 6/27 
BipolarII 
 3 Todder et al 2006 Germany MDD Type II 49 (13) 48 B,H SCID AD,AP as Baune 2007 
 4 Todder et al 2009 Germany MDD Type II 49 (13) 48 B,H SCID AD,AP as Baune 2007 
Berle 5 Berle et al 2010 Norway MDD Type I & II 43 (11) 56 M "standard" AD,AP 7/23 Bipolar II; 1/27 Bipolar I 
Coffield 6 Coffield & Tyron 
2004 




et al  2012 
Denmark MDD No 38 (12) 69 H SCID AD Study tested Unipolar vs Bipolar vs 
Controls. Data from bipolar not shown 
Foster 8 Foster et al 1978 USA MDD No 25 (5) 57 None ns AD  
Glod 9 Glod et al 1992 USA SAD No 38 (13) 81 None ns None  
Godfrey 10 Godfrey & Knight 
1984 
NZ MDD Type II na na Other "standard" NS  
Haynes 11 Haynes et al  
2006 
USA MDD No 44 (13) 31 H SCID AD n=41 of the sample were veterans; 
uneven medication status, 
Joffe 12 Joffe et al 2009 USA MDD No 51 (5) 100 B SCID NS All menopausal, 70% MDD; 17% 
Dysthymia; 13% minor dep 
Korszun 13 Korszun et al 
2002 
USA MDD No 46 (3) 55 None SCID AD two additional groups, fibromyalgia +- 
depression excluded from analysis. 
Raoux 14 Raoux 1994 France MDD Type I & II 44 (21) 78 M "Clinical" AD 5/26 Bipolar  
                                                 
1
 MDD; Major Depressive Disorder; SAD: Seasonal Affective Disorder.  
2
 B: Beck Depression Inventory; H: Hamilton Depression Rating Scale; M: Montgomery Asberg Depression Rating Scale 
3
 AD: Antidepressant; AP: Antipsychotic (typically Quetiapine XL) 
 - 21 - 
Royant 
Parola 
15 Royant Parola et 
al 1986 
UK MDD Type I & II 55 (na) 83 H,M "Clinical" AD  
Teicher 16 Teicher et al 
1997 
USA SAD No 39 (11) 80 None SCID None  
Volker 02 17 Volker et al 2002 NL MDD No 53 (9) 32 H SCID AD Patients randomised imipramine vs. 
fluvoxamine 
Volker 03 18 Volker et al 2003 NL MDD No 53 (9) 44 H SCID None  
Winkler 19 Winkler et al 
2005 
Austria SAD No 37 (14) 76 H SCID 
(seasonal) 
None recruit by advert 
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Table 2: Study designs and actigraphy details 
 
Study Design Number of participants Actigraphy Details 
 







Baune 2006 Day PP Inpatient 10 10 Wrist 7 14 y 
Baune 2007 Day PP Inpatient 27 27 Wrist 11 11 y 
Todder 2006 Sleep PP Inpatient 27 27 Wrist 7 14 y 
Todder 2009 Both Both Inpatient 27 27 Wrist 7 14 y 
Berle 2010 Day CC Both 23 23 Wrist 14  n 
Coffield 2004 Sleep PP Inpatient 18 21 Wrist 7 28 y 
Faurholt-Jepsen 2012 Both CC Outpatient 20 31 Chest 3  n 
Foster 1978 Day CC Inpatient 7 7 Wrist na  n 
Glod 1992 Day CC ns 26 21 Wrist na  n 
Godfrey 1984 Day PP Inpatient 5 9 Wrist 15 continuous n 
Haynes 2006 Sleep CC Outpatient 39 39 Wrist 5  y 
Joffe 2009 Sleep CC Outpatient 52 51 Wrist 2  y 
Korszun 2002 Day CC Outpatient 9 28 Wrist 6  y 
Raoux 1994 Both PP Inpatient 26 26 Wrist 3 20 y 
Royant Parola 1986 Day PP Inpatient 12 12 Wrist 30 30 y 
Teicher 1997 Day CC Outpatient 25 20 Wrist 3  n 
Volker 2002 Both PP Inpatient 52 52 Wrist 3 28 n 
Volker 2003 Day CC Inpatient 54 64 Wrist 3  y 
Winkler 2005 Both Both Both 17 17 Wrist 7 21 y 
 
 
                                                 
1
 
CC: Case-control design; PP: Pre- post treatment design
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